Delivery Order SPE2DR25D1110-SPE2DR26F13BB
- Not listed
- The Defense Logistics Agency awarded a $1,210.89 delivery order to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (30-count supply) on October 27, 2025, with an ultimate completion date of October 28, 2025. This is a firm fixed price delivery order with no set-aside designation, reflecting competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child award, this delivery order falls under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Kerendia 10 mg tablets (30-count units) valued at $2,456.94. This firm fixed-price delivery order, with an ultimate completion date of October 29, 2025, represents a non-set-aside, competitively awarded contract. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $38,149.93 to supply Kerendia 10 mg tablets (30-count units) with a firm fixed price structure. This competitive award, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract does not utilize a set-aside designation and will be performed at the...
- The Defense Logistics Agency awarded a $4,290.06 delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Kerendia 20 mg tablets (30-count packages). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 13, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Kerendia 10 mg tablets (30-count units) under a firm fixed-price contract valued at $14,979.25. This non-set-aside, competitively awarded delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a delivery order valued at $3,708.36 to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (30-count packages) on June 18, 2025, with completion targeted for June 20, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,430.52 for Kerendia 10 mg tablets (90-count packaging) on July 15, 2025, with an ultimate completion date of July 16, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $4,927.87 delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Kerendia 10 mg tablets (90-count packages). This contract, issued under a firm fixed-price arrangement with no set-aside designation, reflects a competitive award to support federal medical procurement needs. The delivery order is scheduled for completion by October 30, 2025, with performance to be executed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $86,658.21 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (90-count units) on November 7, 2025, with an ultimate completion date of November 10, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,212.34 to AmerisourceBergen Drug Corp for Kerendia 20 mg tablets (30-count units) under a firm fixed price contract type. The award, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a non-competitive delivery order fulfilled by the prime contractor's Conshohocken, Pennsylvania facility. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite...
- SPE2DR25D1110Indefinite Delivery Contract
- SPE2DR25D1110-SPE2DR26F13BBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,478.74 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (30-count units). This contract, issued on November 18, 2025, with an ultimate completion date of November 19, 2025, represents a firm fixed-price delivery order with no set-aside designation. The award was made competitively and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 global pharmaceutical support vehicle through December 2026 that enables the company to supply a wide range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement needs through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies. The company's federal contract performance demonstrates its capability to meet diverse medical supply requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Kerendia, a pharmaceutical product for managing specific medical conditions, will be supplied through this award as part of AmerisourceBergen's ongoing role supporting military and veteran healthcare systems' medication needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 11/18/25 |